4.6 Review

Cytokines as therapeutic targets in skin inflammation

Journal

CYTOKINE & GROWTH FACTOR REVIEWS
Volume 25, Issue 4, Pages 443-451

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.cytogfr.2014.07.008

Keywords

Psoriasis; Atopic dermatitis; Antimicrobial peptides; Microbiome; Pruritus; Keratinocytes

Funding

  1. British Skin Foundation [5035s]
  2. Deutsche Forschungsgemeinschaft (DFG)
  3. German Ministry for Research and Education (BMBF)
  4. National Institute for Health Research (NIHR)
  5. British Skin Foundation [5035s] Funding Source: researchfish

Ask authors/readers for more resources

This review focuses on treatment targets for the most common inflammatory skin diseases, eczema and psoriasis with an emphasis on cytokines expressed in the uppermost layer of the skin which is easily accessible for diagnostic and therapeutic approaches. Recently, a significant body of research has highlighted the influence of the skin barrier and the patients' microbiome on skin inflammatory responses and we will comment on their impact on mediator regulation. Itch is a prominent dermatology symptom which is influenced by cytokines and can via itch-scratch cycle impact on the skin barrier and mediator expression associated with damage. Taking the contribution of pruritus and superficial skin damage into account, we address cytokines as targets for stratified treatment approaches in subgroups of eczema and psoriasis. (C) 2014 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available